Insights from ORION studies: focus on inclisiran safety

被引：8
|
作者：
Catapano, Alberico Luigi [1 ,2 ]
Pirillo, Angela [2 ,3 ]
Norata, Giuseppe Danilo [1 ,3 ]
机构：
[1] Univ Milan, Dept Pharmacol & Biomol Sci, Via Balzaretti 9, I-20133 Milan, Italy
[2] IRCCS MultiMed, Via Milanese 300, I-20099 Milan, Italy
[3] E Bassini Hosp, Ctr Study Atherosclerosis, Via M Gorki 50, I-20092 Milan, Italy
来源：
CARDIOVASCULAR RESEARCH | 2021年 / 117卷 / 01期
关键词：
ANTISENSE OLIGONUCLEOTIDES; RISK;
D O I：
10.1093/cvr/cvaa139
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：24 / 26
页数：3
相关论文
共 50 条
  • [1] Effects of Renal Impairment on the Pharmacokinetics, Efficacy, and Safety of Inclisiran: An Analysis of the ORION-7 and ORION-1 Studies
    Wright, R. Scott
    Collins, Michael G.
    Stoekenbroek, Robert M.
    Robson, Richard
    Wijngaard, Peter L. J.
    Landmesser, Ulf
    Leiter, Lawrence A.
    Kastelein, John J. P.
    Ray, Kausik K.
    Kallend, David
    MAYO CLINIC PROCEEDINGS, 2020, 95 (01) : 77 - 89
  • [2] Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15
    Yamashita, Shizuya
    Kiyosue, Arihiro
    Maheux, Pierre
    Mena-Madrazo, Jorge
    Lesogor, Anastasia
    Shao, Qing
    Tamaki, Yuko
    Nakamura, Hidekazu
    Akahori, Mizuki
    Kajinami, Kouji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (06) : 876 - 903
  • [3] Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11
    Koenig, Wolfgang
    Ray, Kausik K.
    Landmesser, Ulf
    Leiter, Lawrence A.
    Schwartz, Gregory G.
    Wright, R. Scott
    Conde, Lorena Garcia
    Han, Jackie
    Raal, Frederick J.
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2023, 14
  • [4] Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11)
    Wright, R. S.
    Kallend, D.
    Raal, F. J.
    Stoekenbroek, R.
    Koenig, W.
    Leiter, L. A.
    Landmesser, U.
    Schwartz, G.
    Wijngaard, P. L. J.
    Kastelein, J. J. P.
    Ray, K. K.
    EUROPEAN HEART JOURNAL, 2020, 41 : 3009 - 3009
  • [5] ORION-8: one step closer to understanding the safety and efficacy of inclisiran
    Tokgozoglu, Lale
    Norata, Giuseppe Danilo
    CARDIOVASCULAR RESEARCH, 2024, 120 (12) : 1365 - 1366
  • [6] Efficacy and Safety of Inclisiran According to Age: A Pooled Analysis of Phase III Studies (ORION 9, 10 and 11)
    Wright, R. Scott S.
    Ray, Kausik K.
    Raal, Frederick J.
    Kallend, David
    Jaros, Mark
    Koenig, Wolfgang
    Leiter, Lawrence A.
    Landmesser, Ulf E.
    Schwartz, Gregory G.
    Wijngaard, Peter
    Kastelein, John J.
    CIRCULATION, 2020, 142
  • [7] INCLISIRAN AND CARDIOVASCULAR OUTCOMES: ANALYSES FROM ORION-11
    Ray, Kausik Kumar
    Wright, Scott
    Kallend, David
    Koenig, Wolfgang
    Leiter, Lawrence
    Raal, Frederick
    Wijngaard, Peter
    Kastelein, John J. P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 238 - 238
  • [8] Efficacy and safety of inclisiran in real world practice: insights from the Cholinet registry
    Basile, C.
    Gargiulo, P.
    Merlini, P. A.
    Brunetti, N. D.
    Musumeci, G.
    Casu, G.
    Galasso, G.
    Varbella, F.
    Calabro', P.
    Ciccone, M. M.
    Calo', L.
    Bilato, C.
    Paolillo, S.
    Indolfi, C.
    Perrone-Filardi, P.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [9] Safety and Efficacy of Inclisiran in Patients With Heterozygous Familial Hypercholesterolemia - Results From the Phase 3 ORION-9 Trial
    Raal, Frederick J.
    Ray, Kausik K.
    Kallend, David
    Koenig, Wolfgang
    Wright, R. Scott
    Leiter, Lawrence A.
    Wijngaard, Peter L.
    Kastelein, Johannes J., Jr.
    CIRCULATION, 2019, 140 (25) : E987 - E987
  • [10] Efficacy and Safety of Inclisiran According to Sex: A Pooled Analysis of the ORION 9, 10 and 11 Trials
    Wright, R. Scott S.
    Ray, Kausik K.
    Raal, Frederick J.
    Kallend, David
    Jaros, Mark
    Koenig, Wolfgang
    Leiter, Lawrence
    Landmesser, Ulf E.
    Schwartz, Gregory G.
    Wijngaard, Peter L.
    Kastelein, John J.
    CIRCULATION, 2020, 142
12345